Skip to main content

Custom Pharma solutions

 By combining our world-leading drug development and manufacturing expertise with flexible and adaptive customer service, our custom pharma CDMO solutions help innovators to overcome development hurdles and accelerate your therapeutic to commercial success.


Find the right CDMO to drive your therapeutic to commercial success

At Verapharms, we have over 50 years’ experience navigating the challenges of the global pharmaceutical industry. Through our custom pharma CDMO services, we can help you manage your most complex chemistry and scale-up challenges with confidence.

We offer complete custom services, from pre-clinical to commercialization, providing vital pharmaceutical development, production and analysis solutions at our global network of dedicated manufacturing sites. Our team of experts and cutting-edge instrumentation enables us to deliver life-changing complex chemistry solutions for our customers.



A CDMO partner you can trust

We are committed to building strong relationships with our customers. By developing a true understanding of your needs and aims, we provide the right solutions to accelerate your product to market.

Our team of skilled scientists have extensive expertise in the fastest growing areas of development in the pharmaceutical industry today, and can anticipate the key challenges you may encounter throughout the drug development process. Keeping your project on track is our priority.




How we work with Innovators




Collaboration: We work with our customers to develop efficient, scaled-up processes through added value technology and experience.

Accelerating development: Leveraging our expertise and technology, Veranova enables customers to maximize process efficiency and accelerate speed to market.


Process Development


Our scientists and engineers develop synthetic processes to enable rapid, phase-appropriate product development and commercialization.

Our team has expertise in synthetic organic chemistry, physical organic chemistry and particle engineering. We also have expertise in chromatographic separations from analytical to commercial scale purification.

Our commitment to state-of-the-art development utilizes a wide array of equipment and tools:

  • Reaction kinetics modelling
  • In-line reaction monitoring and particle visualization
  • Flow-chemistry from bench to commercial scale
  • Chemistry automation using Mettler-Toledo Easymax and Optimax systems
  • Process optimization and criticality determination using advanced DoE modelling
  • HPAPI development
  • Thermal hazard assessment utilizing Mettler Toledo RC-1




Analytical Method Development


Our dedicated team of experts and extensive equipment capabilities enable us to deliver quality analytical methods throughout all phases of clinical development, GMP scale up and commercialization in line with ICH and FDA/MHRA/EMEA requirements.

Our technical team develop, qualify, transfer, and validate analytical methods as part of our integrated approach to process and product development. This enables full analytical support for regulatory starting materials (RSM) and in-process control strategies in addition to intermediate and API characterization with the flexibility needed for phase appropriate development and GMP manufacturing of drug candidates.

  • Method development, qualification, validation, and transfer in compliance with global regulatory guidelines/ICH Q2(R1)
  • ICH stability including photostability
  • Forced degradation studies
  • Impurity isolation, identification, and characterization.
  • Characterization of APIs and precursors
  • Reference material program
  • cGMP Regulatory Starting Material assessment
  • Potential mutagenic impurity (PMI) & nitrosamine assessment and testing

Our global analytical development capabilities facilitate the full range of analytical techniques required to test for the purity, identity, potency, chiral purity and safety of the investigational product at all clinical phases.

We use state-of-the-art spectrometry, spectroscopy, chromatography, and characterization instrumentation to deliver high quality methods to the specifications required:

  • UPLC with TUV, PDA, and QDa detectors
  • HPLC with VWD, PDA, CAD, MALS, RI, FD, and MS detectors
  • GC (direct and headspace injection) with FI, EC, and MS detectors
  • IC with conductivity and UV detectors
  • Spectroscopy (IR, NMR, ICP-OES, ICP-MS, UV/Vis, Polarimeter)
  • Physical Characterization (TGA, DSC, XRPD and Particle Size Analyzer)
  • Thermal Analysis (TGA & DSC) and Wet Chemistry (TOC, Titrators, RI)



Popular posts from this blog

Polymorph, Salt & Cocrystal Screening

 Selecting the optimal solid form of an API during early drug development can mitigate the risk of failure later in development. This can be achieved through polymorph, salt and cocrystal screening. Polymorph screening  aims to identify all relevant forms of an API, investigate their properties and choose the optimal crystalline form. Polymorphism control is exceptionally important and conducting these screens can help prevent the appearance of new forms in the latter stages of development. We focus on establishing the interconversions between forms, the relative stability of forms and understanding the monotropic or enantiotropic relationship between polymorphs when required. Polymorph screening is a regulatory requirement whether a salt, cocrystal or free form compound is chosen for development. Salt screening  is an approach to quickly identify and assess the salt forms of an API. This allows drug developers to modify the physical properties of an API while preserving ...
Read more